As millions of patients are pushed to get on these drugs to aid in weight loss, there is cause for some worry, according to the report
(2) Moderate: some RCTs or large cohort studies
Given the uncertainty around compounded tirzepatide availability, that flexibility has significant value that is worth the monthly premium
A piece on the Mayo Clinic Press website calls it a "promising supplement" but adds that it is "not a magical weight-loss solution." Bad news: it refers to the "nature's Ozempic" thing as "good marketing," but says that is not "necessarily honest or helpful." So, what is the truth
Well assess your symptoms, review your treatment history, and determine whether SPRAVATO is the right option for you
Summary: Retatrutide is not currently available in the UK or globally, as it remains an investigational medicine without marketing authorisation, accessible only through authorised clinical trials as of mid-2025